TSN Stock Analysis: Tyson Foods | NYSE
Farm Products | NYSE, USA | Market Cap: 20.112m USD | 12M Return: -0.3% | US9024941034 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 169M
EPS Trend: 87.1%
Qual. Beats: 0
Rev. Trend: 95.8%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Tyson Foods, Inc. (NYSE: TSN) is a U.S.-based, large-cap packaged food company operating globally through four reporting segments: Beef, Pork, Chicken, and Prepared Foods. The company operates a vertically integrated protein value chain - from livestock procurement and breeding stock production through slaughter, fabrication, and further processing into branded retail and foodservice products. Its brand portfolio includes well-known names such as Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Wright, and Aidells, spanning ready-to-eat sandwiches, frozen proteins, deli meats, breakfast items, and ethnic foods. Tyson distributes through grocery retailers, warehouse clubs, foodservice operators, military commissaries, and export channels, serving both retail and institutional end markets. Founded in 1935 and headquartered in Springdale, Arkansas, the company has been publicly traded on the NYSE since 1986 and sits within the Consumer Staples sector (GICS Sub-Industry: Packaged Foods & Meats), a category characterized by stable demand, high commodity-input sensitivity, and consolidated competition among a small number of large-scale protein processors.
- Beef segment margins squeezed by tight cattle supplies
- Prepared Foods branded portfolio lifts higher-margin revenue mix
- Capital allocation prioritizes debt reduction and shareholder returns
| Net Income: 574.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.30 > 1.0 |
| NWC/Revenue: 5.14% < 20% (prev 7.70%; Δ -2.56% < -1%) |
| CFO/TA 0.06 > 3% & CFO 2.00b > Net Income 574.0m |
| Net Debt (7.27b) to EBITDA (2.60b): 2.79 < 3 |
| Current Ratio: 1.43 > 1.5 & < 3 |
| Outstanding Shares: last quarter (350.0m) vs 12m ago 0.57% < -2% |
| Gross Margin: 6.16% > 18% (prev 7.20%; Δ -1.04% > 0.5%) |
| Asset Turnover: 154.5% > 50% (prev 148.5%; Δ 6.05% > 0%) |
| Interest Coverage Ratio: 3.0 > 6 (EBIT TTM 1.22b / Interest Expense TTM 405.0m) |
| A: 0.08 (Total Current Assets 9.46b - Total Current Liabilities 6.60b) / Total Assets 35.6b |
| B: 0.52 (Retained Earnings 18.6b / Total Assets 35.6b) |
| C: 0.03 (EBIT TTM 1.22b / Avg Total Assets 36.0b) |
| D: 1.04 (Book Value of Equity 18.1b / Total Liabilities 17.4b) |
| Altman-Z'' = 3.55 = A |
| DSRI: 0.97 (Receivables 2.46b/2.45b, Revenue 55.7b/54.1b) |
| GMI: 1.17 (GM 7.20% / 6.16%) |
| AQI: 1.01 (AQ_t 0.49 / AQ_t-1 0.48) |
| SGI: 1.03 (Revenue 55.7b / 54.1b) |
| TATA: -0.04 (NI 574.0m - CFO 2.00b) / TA 35.6b) |
| Beneish M = -2.87 (Cap -4..+1) = A |
As of August 28, 2026, the stock is trading at USD 55.35 with a total of 2,224,651 shares traded. Over the past week, the price has changed by -5.22%, over one month by -8.83%, over three months by -15.46% and over the past year by -0.27%.
Current recommended Stop Loss: 53.50 (which is 3.3% or 1.3 ATR below the current price).
Tyson Foods has received a consensus analysts rating of 3.38. Therefore, it is recommended to hold TSN.
- StrongBuy: 2
- Buy: 2
- Hold: 8
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 68.8 | 24.2% |
P/E Trailing = 35.7312
P/E Forward = 12.5471
P/S = 0.3611
P/B = 1.1261
P/EG = 1.0438
Revenue TTM = 55.7b USD
EBIT TTM = 1.22b USD
EBITDA TTM = 2.60b USD
Long Term Debt = 6.58b USD (from longTermDebt, last quarter)
Short Term Debt = 1.43b USD (from shortTermDebt, last quarter)
Debt = 8.01b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.27b USD (calculated: Debt 8.01b - CCE 740.0m)
Enterprise Value = 27.4b USD (20.1b + Debt 8.01b - CCE 740.0m)
Interest Coverage Ratio = 3.0 (Ebit TTM 1.22b / Interest Expense TTM 405.0m)
EV/FCF = 23.58x (Enterprise Value 27.4b / FCF TTM 1.16b)
FCF Yield = 4.24% (FCF TTM 1.16b / Enterprise Value 27.4b)
FCF Margin = 2.08% (FCF TTM 1.16b / Revenue TTM 55.7b)
Net Margin = 1.03% (Net Income TTM 574.0m / Revenue TTM 55.7b)
Gross Margin = 6.16% ((Revenue TTM 55.7b - Cost of Revenue TTM 52.3b) / Revenue TTM)
Gross Margin QoQ = 6.64% (prev 7.05%)
Tobins Q-Ratio = 0.77 (Enterprise Value 27.4b / Total Assets 35.6b)
Interest Expense / Debt = 5.06% (Interest Expense 405.0m / Debt 8.01b)
Taxrate = 27.07% (222.0m / 820.0m)
NOPAT = 886.1m (EBIT 1.22b * (1 - 27.07%))
Current Ratio = 1.43 (Total Current Assets 9.46b / Total Current Liabilities 6.60b)
Debt / Equity = 0.44 (Debt 8.01b / totalStockholderEquity, last quarter 18.1b)
Debt / EBITDA = 2.79 (Net Debt 7.27b / EBITDA 2.60b)
Debt / FCF = 6.26 (Net Debt 7.27b / FCF TTM 1.16b)
Total Stockholder Equity = 18.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.59% (Net Income 574.0m / Total Assets 35.6b)
RoE = 3.18% (Net Income TTM 574.0m / Total Stockholder Equity 18.1b)
RoCE = 4.93% (EBIT 1.22b / Capital Employed (Equity 18.1b + L.T.Debt 6.58b))
RoIC = 2.98% (NOPAT 886.1m / Invested Capital 29.7b)
WACC = 5.18% (E(20.1b)/V(28.1b) * Re(5.77%) + D(8.01b)/V(28.1b) * Rd(5.06%) * (1-Tc(0.27)))
Discount Rate = 5.77% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -62.89 | Cagr: -0.63%
[DCF] Terminal Value 73.87% ; FCFF base≈1.22b ; Y1≈1.11b ; Y5≈978.5m
[DCF] Fair Price = 29.37 (EV 15.5b - Net Debt 7.27b = Equity 8.28b / Shares 281.8m; r=8.35% [WACC [floored]]; 5y FCF grow -10.55% → 2.50% )
EPS Correlation: 87.12 | EPS CAGR: 55.23% | SUE: -0.41 | # QB: 0
Revenue Correlation: 95.84 | Revenue CAGR: 2.11% | SUE: -0.92 | # QB: -1
EPS current Quarter (2026-12-31): EPS=1.11 | Chg30d=-1.16% | Revisions=-30% | Analysts=7
EPS current Year (2026-09-30): EPS=3.95 | Chg30d=-2.45% | Revisions=-31% | GrowthEPS=-4.1% | GrowthRev=+3.6%
EPS next Year (2027-09-30): EPS=4.48 | Chg30d=-0.52% | Revisions=-18% | GrowthEPS=+13.4% | GrowthRev=+0.6%
[Analyst] Revisions Ratio: -32% (up=8, down=17)